< BACK

 

Dina Chaya

 

Dina Chaya is a Partner on the Private Equity team at OrbiMed. Dina has been investing in the private equity and venture capital healthcare industry since 2001. Prior to joining OrbiMed, Dina worked with Omega Funds and NeoMed, as well as having previously held investment positions with 3i and Index Ventures. Her successful investments include Imago BioSciences, CinCor Pharma, Wilson Therapeutics, EUSA Pharma, Endosense and Novexel. Dina received her B.A. in Natural Sciences from the University of Cambridge and her Ph.D. in Molecular and Cellular Biology from Paris VI University. She is a CFA charterholder.